Assessment of Hedgehog/GLI2 signaling inhibitors within metastatic breast cancers
Hedgehog pathway inhibitors were established as potential remediation treatments for tumor-induced bone disease. Additionally, hypotheses concerning inhibition methods were established for future investigation.
Posted by Greta Clinton-Selin on Friday, June 3rd, 2016 in May 2016, Gli2, Hedgehog Pathway Inhibitor, Metastatic Breast Cancer, PTHrP